Mayo Clinic laboratory and pathology research roundup: June 1
Share this:
The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.
Featured Abstract
Therapeutic trials in adult FSGS: Lessons learned and the road forward.
Focal segmental glomerulosclerosis (FSGS) is not a specific disease entity but a lesion that primarily targets the podocyte. In a broad sense, the causes of the lesion can be divided into those triggered by a presumed circulating permeability factor, those that occur secondary to a process that might originate outside the kidneys, those caused by a genetic mutation in a podocyte or glomerular basement membrane protein, and those that arise through an as yet unidentifiable process, seemingly unrelated to a circulating permeability factor. Via Nature Reviews. Nephrology
Published to PubMed This Week
- P-tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status.
Alzheimers Dementia - Leucine zipper 4 autoantibody: A novel germ cell tumor and paraneoplastic biomarker.
Annals of Neurology - Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors.
Neuro-Oncology - The clinical impact of proteomics in amyloid typing.
Mayo Clinic Proceedings - Angiosarcoma of the adrenal gland.
Mayo Clinic Proceedings - Activity of biodegradable polymeric nanosponges against dual-species bacterial biofilms.
ACS Biomaterials Science and Engineering - XIAP knockdown in alcohol-associated liver disease models exhibits divergent in vitro and in vivo phenotypes owing to a potential zonal inhibitory role of SMAC.
Frontiers in Physiology - Synovial fluid metal ion levels are superior to blood metal ion levels in predicting an adverse local tissue reaction in failed total hip arthroplasty.
Journal of Arthroplasty - In search for biomarkers and potential drug targets for uterine serous endometrial cancer.
Journal of Cancer Research and Clinical Oncology - LPCAT1-TERT fusions are uniquely recurrent in epithelioid trophoblastic tumors and positively regulate cell growth.
PLoS One
